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Abstract 
Toxop/asma gondii is an obligate intracellular protozoan parasite belonging to the 
phylum Apicomplexa. It is found throughout the world, infecting a variety of warm-
blooded animals; overall it infects one in three people worldwide, though local 
prevalence rates vary widely. 
Experimental oral infection of susceptible strains of mice w ith cysts of T. gondii is 
known to provoke an acute inflammatory response in the intestine, known as 
toxoplasmic ileitis. The hypothesis tested in this thesis was that the purinergic P2X7 
receptor plays a critical role in intestinal inflammation. This was tested by infecting 
mice with 10 cysts of the ME49 st rain of T. gondii - three strains of mouse were used: 
BALB/c mice, which are known to be resistant to toxoplasmic ileitis; C57BL/6J mice, 
which are classified as susceptible to toxoplasmic ileitis; and P2X7 receptor knockout 
mice (which are C57BL/6J mice whose gene for the P2X7 receptor has been deleted). 
Following infection, experiments were done to assess the effect of the absence of the 
P2X7 receptor on: (a) weight loss and intestinal pathology; (b) parasite control; (c) 
changes in pro- and anti-inflammatory mediators; and (d) activation of key 
transcrip ion factors and intracellular signalling pathways. 
In vivo studies showed that absence of the P2X7 receptor rendered mice acutely 
susceptible to oral infection with T. gondii ME49. P2X7 receptor knockout mice lost 
weight at a much faster rate and had significantly higher levels of intestinal pathology 
(including swelling, angiogenesis, intestinal villous breakdown and infiltration of 
inflammatory cells) than either C57BL/6J or BALB/c mice. 
In vitro studies confirmed that activation of the P2X7 receptor could induce killing of T. 
gondii ME49. However, intestinal parasite burdens were no different in mice with or 
without the P2X7 receptor, indicating that the inflammatory pathology in the intestines 
of P2X7 receptor knockout mice was not due to uncontrolled replication of T. gondii. 
The pathology and weight loss experienced by P2X 7 receptor knockout mice infected 
with T. gondii was associated w ith significantly elevated ileal levels of the pro-
inflammatory cytokines, IFN-y, MCP-1, TNF, IL-6, IL-12, IL-1~ and IL-18, compared with 
C57BL/6J or BALB/c mice. There were no significant differences observed in the 
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production of the anti-inflammatory cytokines IL-10 and TGF-~ between the three 
strains of mice, ruling out any dysregulation of anti-inflammatory pathway activation in 
the development of toxoplasmic ileitis in P2X7 receptor-deficient mice. 
The single most outstanding difference between the P2X7 receptor knockout mice and 
mice with functional P2X7 receptors was an overproduction of nitric oxide. 
Transcription of iNOS, which codes for the enzyme that generates nitric oxide, is 
activated by the transcription factor, NFKB. A series of in vivo experiments 
demonstrated that, without the P2X7 receptor, mice lack the ability to regulate key 
elements of NF-KB activation, which may have contributed to the over-production of 
nitric oxide and inflammatory cytokines seen in these mice. 
The experiments presented in this thesis improve understanding of the role played by 
the P2X7 receptor in the intestinal immune response and pathology induced by 
infection and reveal a previously unrecognised role for this receptor in the regulation 
of intestinal inflammation . 
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